Horrobin, 1996 - Google Patents
Ascorbic acid and prostaglandin synthesisHorrobin, 1996
- Document ID
- 5694530118630570603
- Author
- Horrobin D
- Publication year
- Publication venue
- Subcellular Biochemistry: Ascorbic Acid: Biochemistry and Biomedical Cell Biology
External Links
Snippet
Among the many proposed actions of ascorbic acid, the regulation of prostaglandin synthesis has not featured prominently. Yet, there has been a steady trickle of papers since the late 1970s that have provided evidence that this could be an important mechanism of …
- 235000010323 ascorbic acid 0 title abstract description 48
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Culp et al. | The effect of dietary supplementation of fish oil on experimental myocardial infarction | |
| US5763484A (en) | Lipids for treatment of disease | |
| Shug et al. | Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia | |
| US5336496A (en) | Inhibitor for delta 5-desaturase | |
| US5116624A (en) | Efa compositions and therapy | |
| US4666701A (en) | Pharmaceutical and dietary compositions | |
| Ziboh et al. | Biological significance of essential fatty acids/prostanoids/lipoxygenase-derived monohydroxy fatty acids in the skin | |
| CN1099610A (en) | Formulation for use in smokers | |
| Dutilh et al. | The role of arachidonate lipoxygenase and fatty acids during irreversible blood platelet aggregation in vitro | |
| EP0139480B1 (en) | Topical preparations containing tars and fatty acids | |
| JP2574153B2 (en) | Drugs for cancer treatment | |
| JPH05316998A (en) | Food composition | |
| US4898885A (en) | Pharmaceutica and dietary compositions | |
| Bell et al. | Diets rich in eicosapentaenoic acid and γ-linolenic acid affect phospholipid fatty acid composition and production of prostaglandins E1, E2 and E3 in turbot (Scophthalmus maximus), a species deficient in Δ5 fatty acid desaturase | |
| Horrobin | Ascorbic acid and prostaglandin synthesis | |
| Dew et al. | Effects of pharmacological retinoids on several vitamin A-metabolizing enzymes | |
| Ramwell | Biologic importance of arachidonic acid | |
| CA1279823C (en) | Pharmaceutical and dietary composition for pre-menstrual syndrome | |
| Morita et al. | A proposed method for exploring anti-aggregatory effects of eicosapentaenoic acid in the rat | |
| Booyens et al. | Chronic arachidonic acid eicosanoid imbalance: a common feature in coronary artery disease, hypercholesterolemia, cancer and other important diseases. Significance of desaturase enzyme inhibition and of the arachidonic acid desaturase-independent pathway | |
| Nakamura et al. | Intravenous infusion of tridocosahexaenoyl-glycerol emulsion into rabbits. Effects on leukotriene B4/5 production and fatty acid composition of plasma and leukocytes. | |
| Ferretti et al. | Modification of prostaglandin metabolism in vivo by long-chain omega-3 polyunsaturates | |
| JPS63230631A (en) | Use of essential fatty acid and prevention or treatment for digestive tumor | |
| Laposata et al. | Eicosadiynoic acid: a non-toxic inhibitor of multiple enzymatic steps in the production of icosanoids from arachidonic acid | |
| Tremoli et al. | Effects of n-3 Fatty Acids on Monocyte Functions |